AAM
EBS icon

Aberdeen Asset Management’s Emergent Biosolutions EBS Stock Holding History

Aberdeen Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$58.9M Buy
1,737,470
+118,894
+7% +$3.67M 0.2% 92
2017
Q1 		$47M Buy
1,618,576
+369,908
+30% +$11.3M 0.17% 110
2016
Q4 		$41M Buy
1,248,668
+252,634
+25% +$7.57M 0.16% 123
2016
Q3 		$31.4M Buy
996,034
+271,016
+37% +$7.87M 0.11% 145
2016
Q2 		$20.4M Buy
725,018
+242,766
+50% +$9.52M 0.08% 204
2016
Q1 		$17.5M Buy
482,252
+139,526
+41% +$4.93M 0.06% 208
2015
Q4 		$10.3M Buy
342,726
+69,026
+25% +$2.41M 0.04% 289
2015
Q3 		$7.8M Buy
273,700
+1,800
+0.7% +$59.3K 0.03% 304
2015
Q2 		$8.96M Buy
271,900
+110,100
+68% +$3.41M 0.03% 285
2015
Q1 		$4.65M Buy
161,800
+25,900
+19% +$743K 0.01% 393
2014
Q4 		$3.7M Buy
135,900
+1,600
+1% +$38.1K 0.01% 437
2014
Q3 		$2.86M Buy
134,300
+27,100
+25% +$621K 0.01% 555
2014
Q2 		$2.41M Buy
+107,200
New +$2.5M 0.01% 613

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aberdeen Asset Management's EBS Position: Q2 2017 in Review

Aberdeen Asset Management increased its Emergent Biosolutions (EBS) stake by 7.3% in Q2 2017, buying an estimated $3.67M and bringing the position to 1,737,470 shares worth $58.9M. The position accounts for 0.2% of the portfolio, ranked #92.

Aberdeen Asset Management first reported a position in EBS in Q2 2014 and has held it in 13 quarters since. 181 funds tracked by Wall St. Rank hold EBS as of Q2 2017.

  • Aberdeen Asset Management held 1,737,470 shares of Emergent Biosolutions worth $58.9M as of Q2 2017.
  • Aberdeen Asset Management bought 118,894 Emergent Biosolutions shares in Q2 2017, an estimated $3.67M.
  • Emergent Biosolutions made up 0.2% of Aberdeen Asset Management's portfolio in Q2 2017, its #92 holding.
  • Aberdeen Asset Management first reported a position in Emergent Biosolutions in Q2 2014 and has held it in 13 quarters since.
  • 181 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.